In an investigative report in partnership with KFF Health News, NBC News’ Anne Thompson reports on the growing cases of overdoses involving GLP-1 weight loss drugs.
For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com
» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Subscribe to Here's the Scoop podcast: https://www.nbcnews.com/heres-the-scoop-daily-podcast
» NBC News App: https://apps.nbcnews.com/mobile
» Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
» Visit NBCNews.Com: http://nbcnews.to/ReadNBC
» Find NBC News on Facebook: http://nbcnews.to/LikeNBC
» Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
» Follow NBC News on Instagram: http://nbcnews.to/InstaNBC
#GLP #Weightloss #ozempic
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans MarketWatch —
- Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns NBC News —
- Alarming rise in weight loss drug overdoses NBC News —
- CVS Caremark to cover Foundayo, Zepbound obesity drugs UPI —
- CVS expands access to blockbuster weight-loss drugs in surprise reversal The Independent —
Alarming rise in weight loss drug GLP-1 overdoses
NBC News
— — 3min